What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Cian Healthcare Limited IPO?

Cian Healthcare Limited IPO has received a total subscription of 0.00 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Cian Healthcare Limited

ListedSME

Healthcare & Pharmaceuticals · BSE

Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.

Price Band

₹61 – ₹65

Issue Size

₹38.00 Cr

Lot Size

2000 shares

GMP

—

Est. Listing

₹65

at current GMP

Subscribed

—

Open

2 May 2019

15 May 2019

Allotment

20 May 2019

Refund

21 May 2019

Demat Credit

22 May 2019

Listing

23 May 2019

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

0.00x

Total Demand

QIB Multiplier

0.00x

Institutions & Funds

NII / HNI

0.00x

High Net-Worth

Retail (RII)

0.00x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 0.00x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
Qualified Institutional (QIB)	2,923,077	—	0.00x
Non-Institutional (NII / HNI)	876,923	—	0.00x
Retail Individual (RII)	2,046,154	—	0.00x
Total	5,846,154	0	0.00x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.00x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,023	1,023	1.00x
HNIs (10L +)	7	7	1.00x
HNIs (2-10L)	31	31	1.00x
Total Applications	1,061	1,061	1.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Cian Healthcare Limited Public Issue & Market Profile

Cian Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹38 Crores. The shares are offered at a price band of ₹61 to ₹65 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,30,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-05-22, while un-allotted funds or UPI block mandates will be released on 2019-05-21.

Frequently Asked Questions

What is Cian Healthcare Limited IPO GMP today?

Currently, Cian Healthcare Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹61 to ₹65 per equity share.

What is the expected profit per lot for Cian Healthcare Limited IPO?

The retail lot size is 2000 shares requiring a minimum application amount of ₹1,30,000. Expected listing price is ₹65 per equity share.

What is the issue size and price band for Cian Healthcare Limited IPO?

The Cian Healthcare Limited IPO aggregate issue size is ₹38 Crores with an equity price band set at ₹61 to ₹65 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,30,000.

How can I check Cian Healthcare Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Cian Healthcare Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2019-05-20. Investors can verify status using PAN card or application number.

When is the listing date for Cian Healthcare Limited IPO?

Cian Healthcare Limited shares are scheduled to list on BSE on 2019-05-23.